If you had lung cancer, you’d take one kind of drug. If you had liver cancer, you’d take another drug. Makes sense, right? But scientists have found another, more effective, more targeted way to treat cancer — one that you need a code to unlock. In this episode we look at the surprising history and the hopeful future of immunotherapy, and how the genetic code of cancer itself has been used to find a way to treat the disease.

Featuring:

• Neeha Zaidi is a medical oncologist at Johns Hopkins Sidney Kimmel Comprehensive Cancer Centre. 
• Mike Yee is Jefferies’ managing director and senior biotech analyst
• Neville Sanjana is a core faculty member at the New York genome center and also an assistant professor of biology at NYU

Healthcare innovations aren’t just about drugs, but how care is delivered. But one of the fastest-growing areas of health care is focusing less on WHAT’s wrong with you, but WHERE the healing actually happens, and HOW doctors can deliver that care right to your home. In this episode we learn how a fitness craze from the 80’s is helping provide medical care right to a patient’s front door.

Featuring:

• Raphael Rakowski is the founder of Medically Home
• Elizabeth Krupinski is a professor at Emory University and the co-author of the book Understanding Telehealth
• Brian Tanquilut is a healthcare services analyst at Jefferies

The discovery of DNA in the 1850s allowed us to see into the genetic code of individual humans. Now gene editing, a technique by which the gene or genes that make us susceptible to some diseases, allows that code to be rewritten. In this episode we look at the ways in which gene editing is being used to turn that century-old breakthrough into the future of medicine.

Featuring:

• Pino Ciaramella is the chief scientific officer and president of Beam Therapeutics 
• Paul Offit is the director of the Vaccine Education Centre at the Children’s Hospital of Philadelphia, and a professor at the University of Pennsylvania. He is the author of the book You Bet Your Life: The Long and Risky History of Medical Innovation  
• Neville Sanjana is a core faculty member at the New York genome center and also an assistant professor of biology at NYU
• Will Sevush is Jefferies’ healthcare desk specialist

Thanks to modern medicine, we are living longer lives than ever before. But our longer lives have led to an increase in age-related degenerative illnesses like Alzheimer’s disease, Parkinson’s and ALS – neurological degenerative disorders that have proven very difficult to treat because of one of the strongest security systems in the human body: The Blood Brain Barrier. This episode looks at how an idea as old as the Trojan Horse could be used to finally break down that barrier for good.

Featuring:

• Ryan Watts is the founder and CEO of Denali Therapeutics
• Mike Yee is Jefferies’ managing director and senior biotech analyst
• Rachita Sumbria is an associate professor at the Chapman University School of Pharmacy

We kick off this new season with a medical breakthrough story you might THINK you know, but isn't that straightforward. We dive into how the "speedy" development of mRNA vaccines is actually a story with decades of twists and turns. In this episode we look at the mRNA technology that is behind many COVID-19 vaccines, and how an idea that once looked like it was destined to fail got a new life just in time to save so many of ours.

Featuring:

• Dr. Thomas Madden is a biochemist and founder and CEO of Acuitas Therapeutics
• Mike Yee is Jefferies’ managing director and senior biotech analyst
• Joe Miller is a reporter for the Financial Times and the author of The Vaccine: Inside the Race to Conquer the COVID-19 Pandemic

Throughout this season, we are exploring some of the amazing medical breakthroughs that have changed lives – and continue to change what’s possible in the world of medicine. And all of this progress stems from investment: of time, of money, of research and ingenuity. In this episode, we’re looking at the common thread that links all the incredible stories we’ll be hearing over the coming season: that alchemy that brings about these life-saving innovations in healthcare.

Featuring:

• Rachita Sumbria is an associate professor at the Chapman University School of Pharmacy
• Neeha Zaidi is a medical oncologist at Johns Hopkins Sidney Kimmel Comprehensive Cancer Centre.
• Will Sevush Will Sevush is Jefferies’ healthcare desk specialist
• Mike Yee is Jefferies’ managing director and senior biotech analyst

Invisible Forces is a podcast that investigates the unseen influences that drive our spending, our saving and our global economy. 

Hosted by Jefferies' insider Shannon Murphy, season three is all about one invisible force – the alchemy that can turn a series of unlikely events, surprises and setbacks into medicine’s biggest successes.

We’ll hear from biotech industry leaders and our own Jefferies experts about some of the biggest breakthroughs in medical history – and the investments that brought them into reality.
 

Culturally in 2020, the conversation around racial injustice has hit a breaking point. COVID-19 exacerbated inequities in health outcomes for Black and Latino Americans, and in the wake of George Floyd’s death, we’ve seen a massive movement for enduring change. The people have spoken. But how will businesses, markets and economies respond?

Today, consumers are seeking ways to support the Black-owned businesses with their dollars, and companies are looking to hire more equitably and inclusively. Even our technology is getting a redesign – to correct biases built right into the programming of tech tools we use everyday.

Hosts Shannon Murphy and Erin Shea are joined by colleague Nadia Batchelor to explore how this powerful movement can create lasting changes in businesses around the world. 

Featuring Nadia Batchelor, Head of Jefferies’ Global Corporate Access Team and the founder and head of J-NOBLE - Jefferies Network of Black and Latinx Employees.

Also featuring:

• Kristina Liburd is the founder & CEO of Viageur and the organizer behind the Black Startup Collective, a directory of Black-owned startups in Boston.
• Stephanie Wemusa is the VP of Diversity and Inclusion for TalVista - a startup that develops tools to support equitable hiring.
• Boyuan Gao is the founder and principle of Project Inkblot, a design for diversity consultancy.
• Evie Cheung is a designer and researcher, exploring the biases built into AI-powered smart voice assistants.